
The central serotonin2B receptor as a new pharmacological target for the treatment of dopamine-related neuropsychiatric disorders: Rationale and current status of research
Keywords: 5-HT; serotonin; 5-HT2BR; 5-HT2B receptor; AC; adenylate cyclase; APDs; antipsychotic drugs; cAMP; cyclic adenosine monophosphate; CNS; central nervous system; DA; dopamine; DAG; diacylglycerol; DARPP-32; DA and c-AMP-regulated phosphoproteins Mr 32Â kDa;